Multistakeholder Perceptions of Additional Value Elements for United States Value Assessment of Health Interventions-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Multistakeholder Perceptions of Additional Value Elements for United States Value Assessment of Health Interventions

Published:2024-01 Issue:1 Volume:27 Page:15-25
ISSN:1098-3015
Container-title:Value in Health
language:en
Short-container-title:Value in Health

Author:

McQueen R. Brett,Inotai Andras,Zemplenyi Antal,Mendola Nick,Németh Bertalan,Kalo Zoltan

Funder

Pharmaceutical Research and Manufacturers of America Foundation

Publisher

Elsevier BV

Subject

Public Health, Environmental and Occupational Health,Health Policy

Reference33 articles.

1. Are drugs priced in accordance with value? A comparison of value-based and net prices using institute for clinical and economic review reports;Bloudek;Value Health,2021

2. Toward a broader concept of value: identifying and defining elements for an expanded cost-effectiveness analysis;Garrison;Value Health,2017

3. Stakeholder-engaged derivation of patient-informed value elements;dosReis;Patient,2020

4. Patient and payer preferences for additional value criteria;Jakab;Front Pharmacol,2021

5. Defining elements of value in health care-A health economics approach: an ISPOR special task force report [3];Lakdawalla;Value Health,2018

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Value based healthcare and Health Technology Assessment for emerging market countries: joint efforts to overcome barriers;Expert Review of Pharmacoeconomics & Outcomes Research;2024-09-02

2. Can Generalized Cost-Effectiveness Analysis Leverage Meaningful Use of Novel Value Elements in Pharmacoeconomics to Inform Medicare Drug Price Negotiation?;Value in Health;2024-08

3. Development of a Prioritization Framework to Aid Healthcare Funding Decision Making in Health Technology Assessment in Australia: Application of Multicriteria Decision Analysis;Value in Health;2024-07

4. Pharmaceutical innovativeness index: methodological approach for assessing the value of medicines – a case study of oncology drugs;Expert Review of Pharmacoeconomics & Outcomes Research;2024-06-13

5. Development of the Emirates Multi-Criteria Decision Analysis Tool for Orphan Drugs;Cureus;2024-02-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3